Literature DB >> 8472285

Role of locally formed angiotensin II and bradykinin in the reduction of myocardial infarct size in dogs.

K Noda1, M Sasaguri, M Ideishi, M Ikeda, K Arakawa.   

Abstract

OBJECTIVE: The aim was to investigate the role of local formation of angiotensin II and bradykinin in the reduction of myocardial infarct size.
METHODS: Bilaterally nephrectomised male mongrel dogs were used. Effects were compared of pretreatment with three inhibitors of angiotensin II forming enzyme-captopril (an angiotensin converting enzyme inhibitor), nafamostat (a serine protease inhibitor), and chymostatin (a cysteine protease inhibitor)--on left anterior descending coronary artery occlusion. Haemodynamic variables were monitored and blood was collected from the anterior interventricular vein and the aorta. Angiotensin I, angiotensin II, and bradykinin were measured by radioimmunoassay. After 90 min of occlusion, infarct sizes were determined by a macroscopic enzyme technique.
RESULTS: Angiotensin II release into the anterior interventricular vein increased from 0.03(SEM 1.19) pg.min-1 (before coronary occlusion) to 4.64(1.37) pg.min-1 (n = 14, p < 0.05), while angiotensin I release and plasma renin activity remained unchanged. The increase in angiotensin II release was inhibited by nafamostat and chymostatin, but not by captopril. Bradykinin release increased from -3.18(2.72) (before coronary occlusion) to 34.7(12.3) pg.min-1 (n = 14 p < 0.05) by 30 min after occlusion. This increase was augmented by captopril, from 4.10(2.86) before occlusion to 97.8(39.6) pg.min-1 at 5 min after occlusion (n = 12, p < 0.05), but not by nafamostat or chymostatin. Infarct size was smaller (p < 0.05) in the captopril group than in the control group.
CONCLUSIONS: Angiotensin II is locally produced in the ischaemic heart by both serine protease(s) and chymostatin inhibitable protease(s), but not by angiotensin converting enzyme. From the reduction in myocardial infarct size produced by angiotensin converting enzyme inhibition, it seems that bradykinin accumulation may play a more important role than the suppression of angiotensin II formation.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8472285     DOI: 10.1093/cvr/27.2.334

Source DB:  PubMed          Journal:  Cardiovasc Res        ISSN: 0008-6363            Impact factor:   10.787


  11 in total

Review 1.  Therapeutic potential of ischaemic preconditioning.

Authors:  R J Edwards; A T Saurin; R D Rakhit; M S Marber
Journal:  Br J Clin Pharmacol       Date:  2000-08       Impact factor: 4.335

2.  Stimulation of phosphatidylinositol hydrolysis, protein kinase C translocation, and mitogen-activated protein kinase activity by bradykinin in rat ventricular myocytes: dissociation from the hypertrophic response.

Authors:  A Clerk; J Gillespie-Brown; S J Fuller; P H Sugden
Journal:  Biochem J       Date:  1996-07-01       Impact factor: 3.857

3.  The effects of Z13752A, a combined ACE/NEP inhibitor, on responses to coronary artery occlusion; a primary protective role for bradykinin.

Authors:  M A Rastegar; F Marchini; G Morazzoni; A Vegh; J G Papp; J R Parratt
Journal:  Br J Pharmacol       Date:  2000-02       Impact factor: 8.739

4.  Role of cardiac renin-angiotensin system in sarcoplasmic reticulum function and gene expression in the ischemic-reperfused heart.

Authors:  S Takeo; Y Nasa; K Tanonaka; F Yamaguchi; K Yabe; H Hayashi; N S Dhalla
Journal:  Mol Cell Biochem       Date:  2000-09       Impact factor: 3.396

5.  Compartmentalization of angiotensin II generation in the dog heart. Evidence for independent mechanisms in intravascular and interstitial spaces.

Authors:  L J Dell'Italia; Q C Meng; E Balcells; C C Wei; R Palmer; G R Hageman; J Durand; G H Hankes; S Oparil
Journal:  J Clin Invest       Date:  1997-07-15       Impact factor: 14.808

6.  Differential presynaptic modulation of noradrenaline release in human atrial tissue in normoxia and anoxia.

Authors:  G Münch; T Kurz; T Urlbauer; M Seyfarth; G Richardt
Journal:  Br J Pharmacol       Date:  1996-08       Impact factor: 8.739

7.  Angiotensin II effects on ischemic focal ventricular tachycardia are predominantly mediated through myocardial AT(2) receptor.

Authors:  Rakesh Gopinathannair; Ashok K Chaudhary; Dezhi Xing; Debra Ely; Wei Zheng; James B Martins
Journal:  Am J Physiol Heart Circ Physiol       Date:  2009-09-25       Impact factor: 4.733

8.  Lack of correlation of hypotensive effects with prevention of cardiac hypertrophy by perindopril after ligation of rat coronary artery.

Authors:  K Chiba; S Moriyama; Y Ishigai; A Fukuzawa; K Irie; T Shibano
Journal:  Br J Pharmacol       Date:  1994-07       Impact factor: 8.739

Review 9.  The kallikrein-kinin system as a regulator of cardiovascular and renal function.

Authors:  Nour-Eddine Rhaleb; Xiao-Ping Yang; Oscar A Carretero
Journal:  Compr Physiol       Date:  2011-04       Impact factor: 9.090

10.  Preconditioning of the response to ischemia/ reperfusion-induced plasma leakage in hamster cheek pouch microcirculation.

Authors:  Fabiana Gomes da Conceição; Cristiane Maria Simonato Conde; Erik Svensjö; Daniel Alexandre Bottino; Eliete Bouskela
Journal:  Clinics (Sao Paulo)       Date:  2012-08       Impact factor: 2.365

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.